A 50-year-old Man with Headache and Cognitive Decline
Neurol 85:e182-e186, Batra, A. & Berkowtiz, A., 2015
Intracranial Neoplasms and Paraneoplastic Disorders, Ependymoma
Adams & Victors Principles of Neurology, Chp 31, pg 655, Ropper, A.H.,et al, 2014
Primary Leptomeningeal Lymphoma
Neurol 81:1690-1696, Taylor, J.W.,et al, 2013
Intraventricular Hemorrhage
UpToDate, Sept, Cucchiara B.L. and Pacelli, J.P., 2011
Nosocomial Bacterial Meningitis
NEJM 362:146-154, van de Beek,D.,et al, 2010
Long-Term Survival with Favorable Cognitive Outcome After Chemotherapy in Primary Central Nervous System Lymphoma
Ann Neurol 67:182-189, Juergens,A.,et al, 2010
Neurosurgery and Pregnancy
JNNP 79:745-752, Ng,J. &Kitchen,N., 2008
Neoplastic Meningitis
Neurologist 12:179-187, Chamberlain,M.C., 2006
Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005
Central Nervous System Relapse in Non-Hodgkin Lymphoma
Arch Neurol 54:854-859, Bollen,E.L.E.M.,et al, 1997
Prognostic Significance of Coexistent Bulky Metastatic CNS Dis in Pts with Leptomeningeal Metastases
Arch Neurol 54:1364-1368, Chamberlain,M.C.&Kormanik,P.A., 1997
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Clinical Outcome in Aggressively Treated Meningeal Carcinomatosis
Arch Neurol 51:457-461, Grant,R.,et al, 1994
Focal Tectal Tumors:Management and Prognosis
Neurol 44:953-956, Squires,L.A.,et al, 1994
Treatment of Leptomeningeal Metastasis with Intravent Admin of Depot Cytarabine (DTC 101)
Arch Neurol 50:261-264, Chamberlain,M.C.,et al, 1993
Clinical Outcome in Aggressively Treated Meningeal Gliomatosis
Neurol 42:252-254, Grant,R.,et al, 1992
Cancer Pain:Management
Lancet 339:1031-1036, Hanks,G.W.&Justins,D.M., 1992
Brain Tumors
NEJM 324:1471-1476, 1555-15641991., Black,P.McL., 1991
Primary Meningeal B Lymphoma Presenting as a Subacute Ascending Polyradiculoneuropathy
JNNP 54:610-613, Julien,J.,et al, 1991
Leptomeningeal Metastases:Indium-DTPA CSF Flow Studies
Neurol 41:1765-1769, Chamberlain,M.C.&Corey-Bloom,J., 1991
Visual Loss in Tuberous Sclerosis
Neurol 41:1915-1917, Dotan,S.A.,et al, 1991
Central Nervous System Metastases from Non-Hodgkin's Lymphoma:Treatment & Prophylaxis
Am J Med 84:425-435, Recht,L.,et al, 1988
Ventriculo-pleural Shunting for Adult Hydrocephalus
Br J Neurosurg 2:503-505, Megison,D.P.&Benzel,E.C., 1988
Chronic Lymphocytic Leukemic Meningitis as a Cause of the SIADH
Cancer 60:191-192, Stagg,M.P.&Gumbart,C.H., 1987
Leukemic Meningitis in B-Cell Chronic Lymphocytic Leukemia
Cancer Treatment Reports 69:687-688, Steinberg,J.P.,et al, 1985
Treatment of Massive Intrathecal Methotrexate Overdose by Ventriculolumbar Perfusion
NEJM 311:386-388, Spiegel,R.J.,et al, 1984
Intraventricular Methotrexate Therapy of Leptomeningeal Metastasis from Breast Carcinoma
Neurol 33:1565-1572, OngerboerdeVisser,B.W.,et al, 1983
Meningeal Carcinomatosis
Arch Neurol 38:696-699, Theodore,W.H.,et al, 1981
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
Treatment for Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation, A Randomzid Clinical Trial
JAMA doi.10.1001/JAMA.2026.0076;2026, Aizer,A.A.,et al, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
Inflammatory Myopathies
NEJM 394:1925-1938, AllenBach,Y. & Benveniste,O., 2026
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025
Frequency, Risk Factors, and Outcomes of Strokes in Patients with Primary Glioma After Cranial Radiation
Neurol 105:e213902, Ryan,D.,et al, 2025
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025
Neuroimaging Findings in Children and Young Adults with Neurotoxicity after CAR T-Cell Therapy for B-Cell Malignancies
Neurol 105:e214086, McGuire,J.L.,et al, 2025
Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
Anticoagulant Usage and Risk of Thromboembolic Events After Ischemic Stroke in Adults with Cancer
Neurol 105:e214325, Balali,P.,et al, 2025
A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus
NEJM 393:2198-2209, 2264, Luciano,M.G.,et al, 2025
Behcets Syndrome
NEJM 390:640-651, Saadoun,D.,et al, 2024
Cavernous Maliformations of the Central Nervous System
NEJM 390:1022-1028, Smith,E.R., 2024
Immunosuppressive Therapy Reversing Obstructive Hydrocephalus in CLIPPERS
Neurol 102:e209396, Yang,Y.,et al, 2024
Vitamin B12 Deficiency:NICE Guideline Summary
BMJ 385:q1019, q1262, Sands,T.,et al, 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024